Literature DB >> 35261670

COVID-19 in Ophthalmology. Current Disease Status and Challenges during Clinical Practice.

Georgios Bontzos1, Anastasia Gkiala1, Christina Karakosta1, Neofytos Maliotis2, Efstathios T Detorakis3.   

Abstract

Purpose: The novel coronavirus disease 2019 (COVID-19) has raised a global public health concern. The purpose of this review is to summarize the evidence currently available on COVID-19 for its ocular implications and manifestations from both pathogenetic and clinical standpoints.
Methods: For this narrative review, more than 100 relevant scientific articles were considered from various databases (PubMed, Google Scholar, and Science Direct) using keywords such as coronavirus outbreak, COVID-19, ophthalmology, ocular symptoms.
Results: Daily healthcare both from patient and physician perspective, as well as on some guidelines regarding prevention and management have dramatically changed over the last few months. Although COVID-19 infection mainly affects the respiratory system as well as the gastrointestinal, cardiovascular, and urinary systems, it may cause a wide spectrum of ocular manifestations. Various challenges have to be faced to minimize exposure for both patients and physicians.
Conclusion: The risk of COVID-19 infection should be considered and medical care should be prioritized for urgent cases. Appropriate management for patients with chronic cases that may result in adverse outcomes should not be neglected, while patients that can be monitored remotely should be identified.

Entities:  

Year:  2021        PMID: 35261670      PMCID: PMC8897783          DOI: 10.26574/maedica.2020.16.4.668

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  149 in total

1.  Estimation of Needed Isolation Capacity for an Airborne Influenza Pandemic.

Authors:  Shobha S Subhash; Gio Baracco; Shelly L Miller; Aaron Eagan; Lewis J Radonovich
Journal:  Health Secur       Date:  2016-07-22

2.  Handheld Adaptive Optics Scanning Laser Ophthalmoscope.

Authors:  Theodore DuBose; Derek Nankivil; Francesco LaRocca; Gar Waterman; Kristen Hagan; James Polans; Brenton Keller; Du Tran-Viet; Lejla Vajzovic; Anthony N Kuo; Cynthia A Toth; Joseph A Izatt; Sina Farsiu
Journal:  Optica       Date:  2018-08-23       Impact factor: 11.104

3.  Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear.

Authors:  Ji-Peng Olivia Li; Dennis Shun Chiu Lam; Youxin Chen; Daniel Shu Wei Ting
Journal:  Br J Ophthalmol       Date:  2020-03       Impact factor: 4.638

Review 4.  The ocular surface, coronaviruses and COVID-19.

Authors:  Mark Dp Willcox; Karen Walsh; Jason J Nichols; Philip B Morgan; Lyndon W Jones
Journal:  Clin Exp Optom       Date:  2020-05-13       Impact factor: 2.742

5.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

6.  Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.

Authors:  Joseph T Wu; Kathy Leung; Gabriel M Leung
Journal:  Lancet       Date:  2020-01-31       Impact factor: 79.321

Review 7.  The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.

Authors:  Yan-Chao Li; Wan-Zhu Bai; Tsutomu Hashikawa
Journal:  J Med Virol       Date:  2020-03-11       Impact factor: 2.327

8.  Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.

Authors:  Manli Wang; Ruiyuan Cao; Leike Zhang; Xinglou Yang; Jia Liu; Mingyue Xu; Zhengli Shi; Zhihong Hu; Wu Zhong; Gengfu Xiao
Journal:  Cell Res       Date:  2020-02-04       Impact factor: 25.617

9.  Epidemiological and clinical features of human coronavirus infections among different subsets of patients.

Authors:  Tatiane K Cabeça; Celso Granato; Nancy Bellei
Journal:  Influenza Other Respir Viruses       Date:  2013-03-05       Impact factor: 4.380

Review 10.  Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review).

Authors:  George Mihai Nitulescu; Horia Paunescu; Sterghios A Moschos; Dimitrios Petrakis; Georgiana Nitulescu; George Nicolae Daniel Ion; Demetrios A Spandidos; Taxiarchis Konstantinos Nikolouzakis; Nikolaos Drakoulis; Aristidis Tsatsakis
Journal:  Int J Mol Med       Date:  2020-05-18       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.